Skip to search formSkip to main contentSkip to account menu

EZH2 Inhibitor CPI-1205

Known as: CPI-1205 
An orally available selective inhibitor of the histone lysine methyltransferase EZH2, with potential antineoplastic activity. Upon oral… 
National Institutes of Health

Search for papers about EZH2 Inhibitor CPI-1205

Search papers